Vaughn, Daniel Edward,Muchmore, Douglas Boyer,Frost, Gregory Ian
申请号：
AU2012271361
公开号：
AU2012271361B2
申请日:
2012.06.15
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Provided are methods for continuous subcutaneous insulin infusion (CSIl) that employ a hyaluronan-degrading enzyme, including a recombinant human PH20 (rHuPH20). The methods can be used to more consistently control blood glucose during the course of CSIL The methods can be used to treat subjects having diabetes or other insulin-associated disease or condition.
